Selected passages from the FDA letter
Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.
Passage 1Failure to adequately ensure that when the results of a process cannot be fully verified by subsequent inspection and test, the process shall be validated with a high degree of assurance and approved according to established procedure, as required by 21 CFR 820.75(a). For example, your firm did not maintain documentation of validation for the following processes:
Citations in the original letter
As cited in this historical letter, not a statement of current regulatory requirements.
- 21 CFR 820.75(a)
- 21 CFR 820.86